Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
10 janv. 2024 07h20 HE
|
Rapid Micro Biosystems, Inc.
Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year Fourth quarter 2023 total revenue expected to be...
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
04 janv. 2024 07h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 janv. 2024 07h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
07 nov. 2023 16h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
03 nov. 2023 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
19 oct. 2023 16h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4
29 sept. 2023 09h25 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase
19 sept. 2023 17h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference
06 sept. 2023 16h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Brevo Meets Consumer Demand for Frictionless Purchasing Experiences with New CRM Solutions
06 sept. 2023 09h00 HE
|
Brevo
Sales, Meetings, Phone, and Payment Functionalities Optimize Customer Interactions SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Brevo, a leading provider of Customer Relationship Management (CRM)...